Table 1.
Drug | Minimum inhibitory concentration (μg/mL) | Resistance breakpoint (μg/mL) | Susceptible (S)/ Resistant (R) |
---|---|---|---|
Ampicillina | ≥ 16 | ≥ 0.5 | R |
Ceftiofura | ≥ 16 | ≥ 8 | R |
Oxacillina | ≥ 16 | ≥ 4 | R |
Penicillina | ≥ 16 | ≥ 0.25 | R |
Erythromycina | ≥ 8 | ≥ 8 | R |
Clindamycina | ≥ 32 | ≥ 4 | R |
Telithromycinb | ≥ 4 | ≥ 4 | R |
Ciprofloxacinb | ≥ 4 | ≥ 4 | R |
Danofloxacina | ≥ 2 | ≥ 0.5 | R |
Enrofloxacina | ≥ 4 | ≥ 4 | R |
Moxifloxacinb | ≥ 4 | ≥ 2 | R |
Gentamicina | ≥ 32 | ≥ 16 | R |
Trimethoprim/sulfamethoxazolea | ≥ 8/176 | ≥ 4/76 | R |
Chloramphenicola | ≥ 16 | ≥ 32 | R |
Rifampinb | ≥ 4 | ≥ 4 | R |
Tetracyclinea | ≤ 2 | ≥ 16 | S |
Nitrofurantoinb | ≤ 32 | ≥ 128 | S |
Quinupristin/dalfopristinb | ≤ 0.5 | ≥ 4 | S |
Vancomycinb | ≤ 1 | ≥ 16 | S |
Daptomycinb | ≤ 0.5 | ≥ 2 | S |
Linezolidb | ≤ 1 | ≥ 8 | S |
CLSI M31-A3. Performance standards for antimicrobial disk and dilution susceptibility tests for bacterial isolates from animals.
CLSI M100-S18. Performance standards for antimicrobial susceptibility testing.